Phase 1 study for people with Colorectal Cancer

Recruiting Phase 1

Sources: ClinicalTrials.gov Checked: 12 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 1
Sponsor Bayer
Registry number NCT07535112
Started 7 April 2026 Today 16 October 2026 Estimated completion 27 July 2029

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Border Medical oncology - Albury Wodonga Regional Cancer Centre Albury NSW Not yet recruiting
Calvary Mater Hospital Newcastle - Oncology Waratah NSW Recruiting
Cabrini Health Oncology Research Malvern VIC Not yet recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 12 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 130

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* KRAS G12D mutated solid tumor

* Participant must be ≥18 years old or the legal age of consent in the jurisdiction in which the study is taking place when signing the screening ICF

* At least one measurable lesion as per RECIST v1.1. outside the CNS

* Eastern Cooperative Oncology Group performance status (ECOG PS) of ≤1

* Male or Female: Contraceptive use by participant or participant's partners should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies.

* Life expectancy of at least 3 months in the opinion of the Investigator

* Histologically/pathologically documented diagnosis of advanced/metastatic adenocarcinoma of the colon and rectum.

* Adequate hematologic and end-organ function

Exclusion Criteria:

* Leptomeningeal disease or carcinomatous meningiti

* Uncontrolled and/or active/symptomatic brain metastases.

* Significant traumatic injury or major surgical procedure within 4 weeks of first dose of study intervention

* Known hypersensitivity to any component of study intervention

* Previous (within 3 years) or concurrent cancer that is distinct in primary site or histology from the cancer being evaluated in the respective substudy.

* Active infection requiring systemic anti-infective therapy within 14 days of first dose of study intervention

* Known HIV infection

* Active Hepatitis B virus (HBV) infection

* Active Hepatitis C virus (HCV) infection

* Significant cardiac disorder

* History of risk factors for torsade de pointes (TdP) (e.g., heart failure, family history of long QT syndrome)

* Participants with inadequately managed diabetes as assessed by the Investigator

* Toxicities from prior anticancer therapy, defined as not having resolved to Grade ≤1 or as specified in the respective substudy protocol as per NCI CTCAE v.6.0 with the following exceptions: Alopecia of any grade, Peripheral neuropathy Grade ≤2, Autoimmune endocrine disorders Grade ≤2 managed with stable endocrine replacement therapy

* History of (non-infectious) pneumonitis/interstitial lung disease (ILD), drug-induced ILD, radiation pneumonitis (unless it has resolved without sequelae without use of steroids), or any evidence of clinically-active pneumonitis/ILD

* History of the following eye disorders: keratitis, ulcerative keratitis

Dates on the record

Started 7 April 2026
Estimated completion 27 July 2029
Registry last updated 5 October 2026
Checked by Voxsanity 12 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 5 October 2026.
  • This page last checked by Voxsanity: 12 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.